Rationale: For unclear reasons, obese children with asthma have higher morbidity and reduced response to inhaled corticosteroids.
overweight/obese children with asthma, dysanapsis was associated with severe disease exacerbations (HR, 1.95; 95% CI, 1.38-2.75) and use of systemic steroids (HR, 3.22; 95% CI, 2.02-5.14).
Conclusions: Obesity is associated with airway dysanapsis in children. Dysanapsis is associated with increased morbidity among obese children with asthma and may partly explain their reduced response to inhaled corticosteroids.
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At a Glance Commentary
Scientific Knowledge on the Topic: Obese children with asthma have higher morbidity and reduced response to inhaled corticosteroids, but the underlying mechanisms are not fully understood.
What This Study Adds to the Field: Being overweight or obese is associated with airway dysanapsis in children with or without asthma. Among obese children with asthma, dysanapsis had a significant clinical impact and may at least partly explain the reduced response to asthma medications in this group of patients.
Obesity and asthma are major public health problems, particularly in industrialized nations. Among children and adults, obesity is a risk factor for asthma, asthma morbidity, reduced quality of life, and reduced response to inhaled corticosteroids (ICSs) (1) (2) (3) . Obesity may impact asthma through multiple mechanisms, including changes in lung mechanics (4) , comorbidities such as gastroesophageal reflux (5) , dietary intake (6) , alterations in insulin and/or glucose metabolism (7) , and systemic inflammation (8) .
Airway dysanapsis is a physiological incongruence between the growth of the lung parenchyma and the caliber of the airways (9) , reflected by an abnormal FEV 1 /FVC despite normal FEV 1 and FVC. Mead proposed that airway length depends on lung volume but airway caliber growth does not (10) . Dysanapsis may occur in otherwise healthy subjects with expiratory flow limitation (11) and may be more pronounced in women than in men (12, 13) .
Most studies have shown that obese adults (with and without asthma) have a reduced FVC but a normal FEV 1 /FVC (suggestive of a restrictive ventilatory deficit). On the contrary, studies in children have shown that obesity is associated with reduced FEV 1 /FVC (an obstructive deficit) (8, (14) (15) (16) (17) . However, rather than low FEV 1 , researchers in several studies have reported a normal or high FEV 1 and a high FVC; thus, we hypothesized that the changes seen in obese children may be related to dysanapsis (normal flows in large lungs). We further hypothesized that obesity is associated with airway dysanapsis in children and that obesity-related dysanapsis leads to increased morbidity in obese children with asthma. We examined these hypotheses using data from pulmonary function test (PFT) clinical databases and from several research cohorts of children with and without asthma. Some of the results of this study were presented as a poster at the 2016 American Thoracic Society International Conference in San Francisco, California (18) .
Methods
See online supplement for details.
Airway Dysanapsis
FVC and FEV 1 z-scores (zFVC and zFEV 1 , respectively) were calculated using Global Lung Initiative equations (19) . "Airway dysanapsis" was defined as normal to high zFVC (>0.674 or 75th percentile), normal zFEV 1 (greater than or equal to 21.645, the fifth percentile, or the lower limit of normal), and low FEV 1 /FVC (,80%). Control subjects were defined by the same zFVC and zFEV 1 
Study Populations
CHP. All PFTs conducted at CHP between August 1991 and April 2014 in children ages 7-19 years were reviewed using a PFT clinical database. We excluded the following diagnoses: cystic fibrosis, bronchopulmonary dysplasia, vocal cord dysfunction, chronic lung disease, obstructive sleep apnea, pneumonia or acute infection, "other," or missing. A total of 381 children with dysanapsis (783 tests) and 907 control subjects (1,523 tests) with complete data were included in the analysis. The electronic medical records of these children were also abstracted for relevant variables: race; asthma diagnosis; scheduled versus sick visit; and hospitalizations, emergency department visits, prednisone courses, use of inhaled steroids, and total number of medications for asthma.
Hartford-Puerto Rico cohort. As part of a case-control study of asthma in Puerto Rican subjects, we recruited 1,127 children (618 with asthma and 509 without asthma) living in San Juan, Puerto Rico, and Hartford, Connecticut (the HPR cohort). Details on subject recruitment and study procedures were reported previously (15, (23) (24) (25) . A total of 147 children with dysanapsis (79 with and 69 without asthma) and 236 control subjects (120 with and 116 without asthma) and complete data were included in this analysis. (27) . A total of 1,041 children were randomized to inhaled budesonide, inhaled nedocromil, or inhaled placebo, and followed for 48 months. A total of 195 children with dysanapsis (2,150 PFTs) and 200 control subjects (1,970 PFTs) were included in this analysis. Information on asthma exacerbations and medication use was recorded in diary cards each day during the trial (27) .
Dutch study cohort. The Dutch study cohort (NL) consisted of data from a 7-year longitudinal study of 622 Caucasian children (ages 12-15 yr at enrollment) from The Hague, the Netherlands, enrolled in secondary school in 1978-1979 (28, 29) . Anthropometric, spirometric, and lung function data were measured twice yearly. Nitrogen single-breath and multiple-breath techniques were used to calculate the residual volume (RVsb and RVmb) (30) and the washout phase III slope (%N 2 /L) (31) . A total of 26 children with dysanapsis (142 PFTs) and 88 control subjects (642 PFTs) with complete data were included in this analysis.
Ethics statement. All studies were approved by the institutional review boards of the corresponding institutions and participating centers.
Statistical Analysis
In our primary analysis, we examined overweight or obesity and dysanapsis. Body ORIGINAL ARTICLE mass index (BMI) z-scores (zBMI) were calculated using formulas from the CDC (32) , and overweight/obesity was assessed using both continuous ( We also performed a random-effects longitudinal analysis in cohorts with available data (CHP, BCH, CAMP, and NL) with three comparisons: "mostly obese" versus "mostly non obese" (children with BMI .85th percentile in .50% vs. ,50% of visits), "mostly obese" versus "never obese" (.50% vs. 0% of visits), and "always obese" versus "never obese" (100% vs. 0% of visits). In addition, we performed cross-sectional and longitudinal combined analyses by pooling the PFTs from all cohorts at the individual level; these analyses were additionally adjusted for study cohort and study site.
Next, we examined dysanapsis and lung function measures in a combined examination of all cohorts for which measures were available, as well as dysanapsis and clinical outcomes in children with asthma. In the NL cohort, we also examined the difference between RVsb and RVmb and the phase III slope (31), both of which are greater when airway obstruction exists (30) . Lung and airway growth were evaluated using the equation MEF = c 3 TLC k , where k values between approximately 0.7 and approximately 1.3 are consistent with isotropic (symmetric) growth (28, 33) and TLC is total lung capacity. We calculated k 50 and k 75 using MEF 50% and maximal expiratory flow at 75% of FVC [MEF 75% ], respectively. Finally, we assessed asthma-related outcomes using linear or logistic regression, as appropriate. In CAMP, survival analysis was performed in overweight/obese participants using log-rank tests of equality and Cox maximum-likelihood proportional hazards models, where each outcome (e.g., asthma exacerbation) was the "failure" event. Cumulative hazard was plotted, stratified by dysanapsis group. All analyses were performed using R v.3.2.2 (R Foundation for Statistical Computing, Vienna, Austria) and STATA v.13 software (StataCorp LP, College Station, TX).
Results
A total of 4,521 children were included in this analysis. The main characteristics of the study populations are shown in Table 1 . Studies included children ages 6-20 years old. The CHP and BCH cohorts include data from children referred to pulmonary clinics for management; the HPR cohort included a population-based and a school-based sample of children with and without asthma; the NHANES cohort included a population-based sample of children without asthma; the CAMP cohort included children with asthma who participated in a clinical trial; and the NL cohort included data from a normative longitudinal study of lung growth in adolescents. Table E1 in the online supplement). We then performed a combined analysis of PFTs for all cohorts (Table 2 ). In this analysis (which was additionally adjusted for cohort and study site), both zBMI (OR, 1.44; 95% CI, 1.31-1.58) and overweight or obesity (OR, 1.95; 95% CI, 1.62-2.35) were associated with dysanapsis. Figure 1 shows the behavior of FEV 1 and FVC by zBMI in children with and without dysanapsis: FEV 1 and FVC had similarly increasing slopes with zBMI regardless of dysanapsis, but in the dysanapsis group FVC was slightly higher (b = 10.18 z-score, or 12.1% of predicted; P , 0.001) and FEV 1 was markedly lower (b = 21.24 z-score, or 214.9% of predicted; P , 0.001). Figure E1 shows these results by individual cohort. Boys had slightly higher odds of dysanapsis than girls ( Figure E2 ); there were no significant differences by race or ethnicity.
Dysanapsis and Obesity

Longitudinal Analysis
The results of the longitudinal analysis of overweight or obesity measures and dysanapsis are shown in Table 3 . In CHP, approximately 20% of children had at least two tests (maximum of 18 tests over a 9-yr span); each 1-point increase in zBMI was associated with a 2.25 times increased odds of dysanapsis, and children who were "always overweight or obese" had 4.34 higher odds of dysanapsis than those who were "never overweight or obese." In BCH, 50% of children had more than 2 tests, and 10% had more than 6 tests (maximum of 20 tests over an approximately Age (in months) 11-yr span); each 1-point increase in zBMI was associated with a 1.82 higher odds of dysanapsis, and children who were "always overweight/obese" had 3.48 times higher odds of dysanapsis than those who were "never overweight/ obese." In CAMP, children had an average of 9.5 tests over approximately 48 months; each 1-point increment in zBMI was significantly associated with a 1.62 times increased odds of dysanapsis, and children who were "always overweight/obese" had 4.95 times higher odds of dysanapsis than those who always had normal weight. In NL, children had an average of 6.5 tests (range, 1-13 over 7 yrs of followup); each 1-point increment in zBMI was associated with a 3.24 times increased odds of dysanapsis, while the dichotomous analyses were not statistically significant. The combined analysis that each 1-point increment in zBMI was associated with a 1.93 times increased odds of dysanapsis, a 3.41 times increased odds of dysanapsis for the comparison of "mostly" obese versus "mostly not" obese, and a 4.18-4.31 times increased odds of dysanapsis for the comparison of "mostly" or "always" obese versus "never" obese.
Dysanapsis and Other Lung Function Measures
We analyzed other lung function measures jointly for the cohorts for which each measure was available. Children with dysanapsis had lower FEF 25 (Figure 1) , with no significant differences in residual volume (RV)/TLC. In NL, dysanapsis was associated with higher VC (b = 1322 ml; P = 0.034), lower MEF 75% (b = 20.281 L/s; P = 0.018), and no changes in closing volume or closing capacity. We also evaluated markers of ventilation inhomogeneity and found that dysanapsis was not associated with the phase III nitrogen slope, but the RVsb 2 RVmb difference was more pronounced in the dysanapsis group (b = 26.9 ml; P = 0.002). Children with dysanapsis had lower mean values of k 50 (0.79 vs. 1.01) and k 75 (0.35 vs. 0.61) (Figure 1 ). After adjustment for age, sex, and FEV 1 , children with dysanapsis had 4.6 times increased odds (95% CI, 1.9-7.3; P = 0.001) of having k 50 values consistent with anisotropic lung and/or airway growth.
Clinical Outcomes
We assessed airway dysanapsis and clinical outcomes in children with asthma. In CHP, children with dysanapsis were more likely to use at least three medications for asthma (OR, 1.72; 95% CI, 1.02-2.90; P = 0.04). In HPR, children with dysanapsis were more likely to use daily albuterol (OR, 8.3; 95% CI, 1.1-64.0; P = 0.04) and miss school due to asthma (OR, 10.5; 95% CI, 1.9-58.5; P = 0.007).
At the randomization visit in CAMP, children with dysanapsis (n = 197) had higher odds of reporting at least one hospitalization for asthma in the year prior to the trial (OR, 3.03; 95% CI, 1.10-8.37; P = 0.033) than those without dysanapsis. Figure 2 shows the proportion of children with dysanapsis by treatment arm during the trial; there was no significant differences in the proportion of children with dysanapsis between budesonide and nedocromil/ placebo at either the beginning or the end of the trial. After adjustment for treatment arm and other covariates, dysanapsis was associated with shorter time to a severe asthma exacerbation requiring emergency department visit, hospitalization, or systemic corticosteroids (b = 23.29 mo; 95% CI, 25.70 to 20.89; P = 0.007). Compared with overweight/obese children without dysanapsis, those with dysanapsis had an increased risk of at least one severe exacerbation (hazard ratio, 1.40; 95% CI, 1.07-1.75; P = 0.014) and of having at least two prednisone bursts between study visits (hazard ratio, 2.53; 95% CI, 1.71-3.73; P , 0.001) (Figure 2) . The effects were all more pronounced in overweight/obese children than in children of normal weight (Table E2) . We found no significant modification of the effect of dysanapsis (or the association between obesity and dysanapsis) by treatment arm. 
ORIGINAL ARTICLE Sensitivity Analyses
We repeated the analysis using different FEV 1 , FVC, and FEV 1 /FVC cutoffs to define dysanapsis, with essentially unchanged results (Table 4 ). In addition, we performed sensitivity analyses with other FEV 1 /FVC or FVC cutoffs (Tables E3 and E4 ), indicating that the associations did not depend solely on our cutoff selection. Finally, we repeated the analysis after excluding subjects with significant bronchodilator response (.12%) or using only post-bronchodilator spirometry (in cohorts with available data), with similar results (data not shown), suggesting that the associations were likely not due to unrecognized bronchoconstriction.
Discussion
In this report, we show that overweight or obesity are associated with airway dysanapsis in children with and without asthma. Moreover, we demonstrate that airway dysanapsis is associated with symptoms, medication use, and severe disease exacerbations in children with asthma. To our knowledge, this is the first report of an association between obesity and airway dysanapsis in childhood, as well as the first report linking dysanapsis to worse disease severity or control in children with asthma. Obesity measures were consistently associated with airway dysanapsis in all cohorts of children, in both cross-sectional and longitudinal analyses. Furthermore, lower FEV 1 , FEF 25-75% , MEF 50% , and/or MEF 75% in the dysanaptic groups strongly suggests that the relative airflow obstruction is likely present throughout airways of all sizes; however, a normal RV/TLC suggests the absence of significant air trapping. These children had larger vital capacity, RV, and TLC, indicating they have larger lungs; this is in sharp contrast to studies in adults that have described a restrictive deficit in obesity, with lower lung volumes and a preserved FEV 1 /FVC (4). Our analysis of the NL data (19) . Top left panel shows the probability of dysanapsis during 48 months in CAMP by treatment arm in children with dysanapsis at randomization. There were no significant differences between the budesonide or nedocromil and/or placebo arms. Error bars represent 95% confidence intervals. The other three panels show cumulative hazard function of dysanapsis for mild exacerbations (top right), severe exacerbations (bottom left), and requiring more than two prednisone bursts between study visits (bottom right). Children with dysanapsis had a higher risk of exacerbations and prednisone courses during the trial.
supports that children with dysanapsis have anisotropic (asymmetric) growth of the lungs and airways. Dysanapsis is merely a reflection of the incongruence between a (faster) growth in lung volume and airway length, and the (slower) increase in airway caliber. Such incongruence may happen physiologically and may be accentuated by several mechanisms, including in utero exposures such as tobacco smoke or vitamin D deficiency (34, 35) , although it is unclear whether these effects would persist later in childhood. Chronic hypoxemia has been associated with a higher risk of dysanaptic lung growth (36) ; dysanapsis may also be present in breathhold divers, who use glossopharyngeal insufflation to force their lung volumes above TLC (providing extra oxygen and preventing compression when diving) (37) . Compensatory lung growth after pneumonectomy may also be dysanaptic (38) .
There is evidence that lung function may "track" from birth throughout life, and this may be influenced by weight from early on. As early as 1990, Barker and coworkers described that low birth weight was associated with low lung function in adults approximately 59-70 years old and with death caused by chronic obstructive pulmonary disease (39) . More recently, den Dekker and colleagues (40) performed a metaanalysis of 25,000 children from 24 birth cohorts and found that greater birth weight and infant weight gain were associated with higher FEV 1 and FVC at school age (independent of gestational age); the increases were greater for FVC than for FEV 1 . Moreover, infant weight gain was associated with lower FEV 1 /FVC and FEF 25-75% . Therefore, the changes we observed may be established very early in life. Further studies are needed to discern whether these changes are fixed or vary, particularly in the transition from childhood to adulthood.
Obesity-related airway dysanapsis was associated with worse clinical outcomes in children with asthma. In CAMP, ICSs had no effect on the association between BMI and dysanapsis, and, despite ICS treatment, children with dysanapsis remained at higher risk of severe asthma exacerbations. Our findings thus suggest that airway dysanapsis partly explains previous reports of a strong link between obesity and increased morbidity (8, 15, 41) or reduced response to treatment (2, 42) in children with asthma. We speculate that obese children with dysanapsis may have airflow obstruction that is anatomical and/or developmental and thus at least partly not related to bronchospasm or airway inflammation.
We found evidence of sex differences, with higher odds of dysanapsis among boys. This could partly explain prior reports that obesity is more consistently associated with worse asthma control in boys than in girls (41) . Some of the initial studies on airway dysanapsis (not related to obesity) described that women have smaller airways than men relative to their lung volumes (10, 43) . Later studies have reported that boys have smaller airways than girls (44, 45) and described changes in dysanapsis ratios before and after puberty (46) . Moreover, a longitudinal populationbased study of children with asthma reported that dysanapsis was more pronounced in boys, but this became less significant with age (47) .
Our study has several limitations. None of the study cohorts was specifically designed to assess obesity and airway dysanapsis; however, we show consistent replication in independent and diverse populations. We cannot completely exclude reversible airflow obstruction, but this is unlikely because we included cohorts of children without asthma, and our results did not change when we used postbronchodilator measurements (when available) or excluded children with a bronchodilator response. Moreover, budesonide treatment had no effect on the association between obesity and dysanapsis. There is evidence that using an arbitrary cutoff may not be the best way to identify "abnormal" lung function; however, we used cutoffs (e.g., FEV 1 /FVC ,0.80) that are widely accepted and used in research and clinical practice. Furthermore, we performed sensitivity analyses using different cutoffs for FVC, FEV 1 , and/or FEV 1 /FVC to define dysanapsis, and the results remained essentially unchanged. We cannot assess whether children with high BMI are able to exhale more forcibly, resulting in higher intrathoracic pressure, more airway compression, and relatively reduced FEV 1 . We lack imaging of the airways or other measurements of airway diameter to confirm findings derived from lung function testing. Finally, we cannot determine whether dysanapsis was solely responsible for the observed differences in asthma outcomes among obese children.
In summary, obesity is associated with airway dysanapsis in children with or without asthma. Among obese children with asthma, dysanapsis has significant clinical impact and may at least partly explain the decreased response to asthma medications in this group of patients. n Author disclosures are available with the text of this article at www.atsjournals.org.
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